I have a Ph.D in Cancer Biology and performed post doctoral studies at the Scripps Research Institute and UC San Diego. I have 10-15 peer reviewed publications in the cancer field and have received multiple competitive grants for my scientific research. My current position at a major pharmaceutical company familiarizes me with drug discovery and drug development in the pharmaceutical industry. As an active industry scientist and skilled investor, I am an active trader who relies on company fundamentals, chart technicals, and stock momentum to generate profits from trading stocks. I hold long-term positions in individual companies as well as frequent trading of sector ETFs. I trade mostly technology and financial stocks, but I am not afraid to trade anything that I think will make me money. Disclaimer: This blog is an expression of my opinion on a particular company or matter. I am not a financial advisor or professional analyst. This is not a solicitation to trade any security. Although I rely on company approved public documents and make all reasonable efforts to confirm the accuracy of my statements, the comments made in my articles should be considered only as opinion and should not be considered as current or as absolute fact. All investors are strongly encouraged to not rely entirely on any single opinion and perform their own due diligence when investing. Investing in equities includes considerable risk, and investors should be prepared for the risk of capital loss.